GMED - Globus Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

GMED is currently covered by 13 analysts with an average price target of $97.85. This is a potential upside of $30.96 (46.28%) from yesterday's end of day stock price of $66.89.

Globus Medical's activity chart (see below) currently has 427 price targets and 313 ratings on display. The stock rating distribution of GMED is 81.25% BUY and 18.75% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 81.68% of the time, taking 244.58 days on average.

Highest price target for GMED is $123, Lowest price target is $78, average price target is $97.85.

Most recent stock forecast was given by RICHARD NEWITTER from TRUIST on 09-Nov-2026. First documented stock forecast 17-Jun-2013.

Currently out of the existing stock ratings of GMED, 26 are a BUY (81.25%), 6 are a HOLD (18.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Nov-2025

$90

$23.11 (34.55%)

$100

13 days ago
(09-Nov-2026)

34/38 (89.47%)

$13.63 (17.85%)

357

Buy Since 17-Dec-2025

$105

$38.11 (56.97%)

$112

16 days ago
(06-Nov-2026)

0/3 (0%)

$33.95 (47.78%)

Buy Since 06-Nov-2024

$78

$11.11 (16.61%)

$104

16 days ago
(06-Nov-2026)

14/16 (87.5%)

$6.95 (9.78%)

264

Buy Since 06-Apr-2020

$100

$33.11 (49.50%)

$99

16 days ago
(06-Nov-2026)

9/13 (69.23%)

$28.95 (40.75%)

210

Buy Since 25-Feb-2026

$100

$33.11 (49.50%)

$117

16 days ago
(06-Nov-2026)

3/7 (42.86%)

$28.95 (40.75%)

499

Show more analysts

Please expand the browser size to see the chart

What is GMED (Globus Medical) average time for price targets to be met?

On average it took 245 days for the stock forecasts to be reached, with an average price target met ratio of 81.68%.

Which analyst most recently updated their price target on GMED (Globus Medical)?

Richard Newitter

Which analyst has the most public recommendations on GMED (Globus Medical)?

Richard Newitter works at TRUIST and has 87 price targets and 48 ratings on GMED

Which analyst is the currently most bullish on GMED (Globus Medical)?

Matt Miksic with the highest potential upside of $56.11

Which analyst is the currently most reserved on GMED (Globus Medical)?

Jonathan Demchick with the lowest potential downside of -$21.89
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?